March 4 (Reuters) - Passage Bio Inc PASG.O:
PASSAGE BIO FY NET INCOME USD -64.767 MILLION
PASSAGE BIO FY INCOME FROM OPERATIONS USD -70.4 MILLION
EXTENDED CASH RUNWAY INTO 1Q 2027
NET LOSS $12.7 MILLION, OR $0.20 PER BASIC AND DILUTED SHARE FOR Q4 2024
Q4 EARNINGS PER SHARE VIEW $-0.20 -- LSEG IBES DATA
Source text: ID:nGNX2J8hqr
Further company coverage: PASG.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.